Psychedelic Spotlight | Psychedelic Spotlight

How An Ancient Cactus Became a Future Medicine
The benefits of mescaline have been regarded for thousands of years.

Read Now
Suicide Prevention With Psilocybin Therapy: Does It Work?
New research finds more than a 60% improvement in patients with suicidal thoughts after treatment with psychedelics.

Read Now
Can Ketamine Shake Its Bad Rap?
Ketamine has a history as a date rape drug. As it becomes a therapy for depression, can it shake its bad rap?

Read Now

How Psychedelics Helped Riley Cote
Heavy Hits: How Psychedelics Helped an Ex-NHL Enforcer Drop the Gloves and Beat His PTSD Straight into the Sin Bin
How Psychedelics Saved Former NBA Star Lamar Odom
Former NBA forward Lamar Odom says the psychedelic drugs ketamine and ibogaine saved him from his drug addiction.
Mike Tyson Credits 5-MeO for His Return to Boxing
Boxing champion Mike Tyson, 54, credits the psychedelic 5-MeO for his return to boxing and his 100-lb weight loss.

Psychedelic Conference to Explore Promising Therapies for Veterans, First Responders

April 8, 2021

Psychedelic Conference to Explore Promising Therapies for Veterans, First Responders

The Heroic Dose conference will explore the use of psychedelic therapies to treat post-traumatic stress disorder, substance abuse, and suicide among military veterans and first responders.

Psychedelic Business News Spotlight: April 9, 2021

April 9, 2021

Psychedelic Business News Spotlight: April 9, 2021

This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.

California Moves Closer to Decriminalizing Psychedelics

April 7, 2021

California Moves Closer to Decriminalizing Psychedelics

With 2 cities in the Golden State already decriminalizing psychedelics, could the rest of California be next?

dr. joseph tucker

April 6, 2021

Interview With Dr. Joseph Tucker

MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

March 31, 2021

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?

The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

April 9, 2021

The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.

PODCASTS

Dustin Robinson

April 6, 2021

Interview With Dustin Robinson

Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.

March 31, 2021/by Psychedelic Spotlight

Interview With Nick Levich

March 31, 2021/by Psychedelic Spotlight

Interview With Pierre Bouchard

March 23, 2021/by Psychedelic Spotlight

Interview With Dr. Steven Mandel

March 23, 2021/by Psychedelic Spotlight

Interview With Sacha Hebbert

Get a Roundup of Psychedelic News Stories in Your Inbox.

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Latest News

CULTURE

MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

March 24, 2021

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.

Former Presidential Candidate Andrew Yang Wants to Decriminalize Psilocybin Mushrooms

March 23, 2021/by Jennifer Walker-Journey

Former Presidential Candidate Andrew Yang Wants to Decriminalize Psilocybin Mushrooms

Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin

March 13, 2021/by Jill Ettinger

Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin Mushrooms

How One Dying Man Received Canada's First End of Life Psilocybin Treatment

March 10, 2021/by Jennifer Walker-Journey

Canada’s First End of Life Psilocybin Treatment Brought Peace to Terminal Man

New App Creates Psychedelic Experience Without the Need for Substances

March 9, 2021/by Jennifer Walker-Journey

Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes

INDUSTRY

Mydecine Prepares to Present Four Novel Psychedelic Candidates

April 8, 2021

Mydecine Prepares to Present Four Novel Psychedelic Candidates

Colorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety and depression.

Psychedelic Business News Spotlight: April 2, 2021

April 2, 2021/by Jennifer Walker-Journey

Psychedelic Business News Spotlight: April 2, 2021

How Field Trip Health Is Leading the Psychedelic Market Boom

April 1, 2021/by Jennifer Walker-Journey

How Field Trip Health Is Leading the Psychedelic Market Boom

Psychedelic Business News Spotlight: March 26, 2021

March 26, 2021/by Jennifer Walker-Journey

Psychedelic Business News Spotlight: March 26, 2021

Psychedelic Business News Spotlight: March 18, 2021

March 19, 2021/by Jennifer Walker-Journey

Psychedelic Business News Spotlight: March 19, 2021

POLICY

Hawaii Establishes Workgroup to Investigate Psilocybin Therapy

April 7, 2021

Hawaii Establishes Workgroup to Investigate Psilocybin Therapy

Hawaii’s Senate unanimously voted to establish a working group to ensure the safety, accessibility, and affordability of psilocybin.

Yale to Study Psilocybin for Cluster Headaches

April 7, 2021/by Jennifer Walker-Journey

Yale to Study Psilocybin for Cluster Headaches

Study Investigates Optimal Dosing for MDMA

April 6, 2021/by Jennifer Walker-Journey

Study Investigates Optimal Dosing for MDMA

A Third Massachusetts City Just Decriminalized Psychedelics

April 5, 2021/by Jennifer Walker-Journey

A Third Massachusetts City Just Decriminalized Psychedelics

UCSF Launches Psychedelic Research Institute

April 1, 2021/by Jennifer Walker-Journey

UCSF Launches New Psychedelic Research Division

RESEARCH

Mass General to Study Psilocybin

March 31, 2021

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.

Use of Psychedelic Shows Correlation With Better Overall Physical Health

March 31, 2021/by Jill Ettinger

Use of Psychedelics Show Correlation With Better Overall Physical Health

Low Doses of LSD Make Opioids Obsolete

March 30, 2021/by Jennifer Walker-Journey

Are Stereotypes Around Psychedelics Slowing Down Research?

March 29, 2021/by Jennifer Walker-Journey

New Research Investigates Psilocybin as OCD Treatment

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

March 26, 2021/by Jill Ettinger

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

TREATMENT

Minnesota Gets Its First Psychedelic Clinic

March 30, 2021

Minnesota Gets Its First Psychedelic Medicine Clinic

The first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will provide ketamine-assisted therapy.

March 29, 2021/by Jennifer Walker-Journey

New Guidance Released for Ketamine, Esketamine Therapy Use

psychedelic mushrooms

March 25, 2021/by Jennifer Walker-Journey

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

Mushroom Conference

March 24, 2021/by Jennifer Walker-Journey

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

Women Are More Likely to Use Psychedelics Than Men

March 23, 2021/by Jill Ettinger

Survey: Women Use Psychedelics More Often Than Men

Get a Roundup of Psychedelic News Stories in Your Inbox.

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.